November 3rd:
FDA Accepts Arana's Anti-inflammatory IND
read article >
September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer
read article >
September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins
read article >
August 6th:
Xenome Strengthens Board with Two New Appointments
read article >
August 6th:
Ciba Elects to Cease Industrial Product Evaluations
read article >
June 24th:
New Pharmaxis Board Appointment
read article >
April 29th:
Benitec secures further rights to HIV Therapeutic
read article >
April 7th:
Starpharma signs agreement with Unilever
read article >
April 1st:
ChemGenex Investigators Present Data on Omacetaxine at International Leukemia Conference
read article >
March 13th:
EMEA Grants Clinuvel Two Orphan Drug Designations
read article >
March 10th:
Progen Announces Commencement Of Global Phase 3Study For PI-88 In Post-Resection Liver Cancer
read article >
March 10th:
Biosignal Partners US Entrepreneur To Commercialise Industrial Anti-bacterial Products
read article >
February 21st:
Healthlinx Announces Appointment of Non Executive Chairman
read article >
February 1st:
Bone Medical Positive New Data From Oral Osteoporosis Drug Trial
read article >
January 17th:
Bone Medical Appoints Intersuisse Bioscience Managers And PhillipCapital Australia To Increase Aust/Asia Coverage
read article >
January 15th:
Genetic Technologies Posts Licensing Program Update
read article >
January 7th:
ChemGenex Appoints Dr. Julie Cherrington to Board of Directors
read article >
|
